ImmuQuest a family business, founded in 2002. Offering a range of unique and novel monoclonal and polyclonal antibodies manufactured to the highest possible quality, at the forefront of scientific research.
Whenever possible, antibodies are tested in applications such as WB, ELISA, IHC (frozen and paraffin sections), and ICC/IF. Many can be supplied in bespoke formats. Most Immuquest antibodies are manufactured under strict control.
The immuquest portfolio is constantly growing, especially in areas of special interest, such as cancer, DNA repair pathways, epigenetics, neuroscience and aging.